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Oxidative stressPrimary open angle glaucoma (POAG) is a degenerative disease commonly associated with aging and elevated
intraocular pressure (IOP). Higher resistance to aqueous humor (AH) outﬂow through the trabecular meshwork
(TM) generates the elevated IOP in POAG; unfortunately the underlying molecular mechanisms responsible for
elevated resistance are unknown. It is widely accepted, however, that differences between normal and POAG
TM tissues are presumably a consequence of cellular dysfunction. Here, we investigated the autophagic function
and response to chronic oxidative stress in TM cells isolated from glaucomatous and age-matched donor eyes.
Glaucomatous TM cells showed elevated senescence-associated-beta-galactosidase (SA-β-Gal) and cellular
lipofuscin, together with decreased steady-state levels of LC3B-II, decreased levels of pRPS6K-T389 and reduced
proteolysis of long-live proteins. Moreover, the glaucomatous cultures failed to activate autophagy when ex-
posed to hyperoxic conditions. These results strongly suggest mTOR-dependent dysregulation of the autophagic
pathway in cells isolated from the glaucomatous TM. Such dysregulated autophagic capacity can have a
detrimental impact in outﬂow pathway tissue, i.e. mechanotransduction, and thus represent an important factor
contributing to the progression of the disease.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Glaucoma is a group of human disorders characterized by a progres-
sive loss of retinal ganglion cells and irreversible vision loss. There are
multiple types of glaucoma, depending on the etiology. Primary open
angle glaucoma (POAG), themost common form, is a disease often coin-
cident with aging and elevated intraocular pressure (IOP) resulting
from excessive resistance to aqueous humor (AH) drainage through
the trabecular meshwork (TM), the primary outﬂow tract. Although
the exact molecular mechanisms or regulatory pathways responsible
for the resistance to outﬂow in POAG have still not been elucidated, it
is widely accepted that differences between normal and POAG TM
tissues are a consequence of cellular dysfunction [1].
Our laboratory previously reported increased number of cells posi-
tively stained for senescence-associated-β-galactosidase (SA-β-Gal) ac-
tivity in the glaucomatous TM tissue compared to age-matched control
tissue [2]. Senescence-associated-β-galactosidase is an activity of the ly-
sosomal β-galactosidase detected at pH 6 (instead of pH 4–5) found in
senescent cells [3]. The nature of this abnormal SA-β-Gal activity,
which is not exclusive but can be observed in conditions others than; IOP, intraocular pressure; AH,
scence-associated beta galacto-
countsperminute;Leu, leucine;
SB, cathepsin B; CTSD, cathepsin
get of rapamycin
r, AERI Bldg, Ofﬁce 4004, Erwin
4085.
).senescence [4], i.e. starvation, remains unknown. Exposure of cultured
TM cells to chronic oxidative stress led to increased SA-β-Gal activity,
which correlated with increased lysosomal content [5]. This increase
in SA-β-Gal activity could be partially blocked in the presence of 3-
methyladenine (3-MA), an inhibitor of autophagosome formation, indi-
cating that activation of macroautophagy is required for the occurrence
of SA-β-Gal [6].
Autophagy, which means “self-eating”, is a general term that refers
to the catabolic process in which cellular components are degraded by
the machinery of the lysosomes. There are three different types of au-
tophagy inmammalian cells based on the delivery route of the cytoplas-
mic material to the lysosomal lumen. Among them, macroautophagy
(referred to here as autophagy) is the most extensively studied. This
particular type of autophagy is characterized by the formation of a
doublemembrane-bound organelle, the autophagosome, which engulfs
the material targeted for degradation. Autophagosomes then fuse with
lysosomes to form autolysosomes, in which the cytoplasmic cargos are
degraded by resident hydrolases [7].
Autophagy has a greater variety of physiological and pathophysio-
logical roles than initially thought, playing important housekeeping
and quality control functions that contribute to health and longevity.
Basal or constitutive autophagy is responsible for the routine turnover
of old or damaged organelles, such as peroxisomes and mitochondria,
as well as degradation of long-lived or aggregate-prone proteins that
are too large to be degraded by the proteasome. Autophagy also acts
as a survival mechanism under conditions of stress or environmental
changes, such as nutrient starvation, oxidative stress, and mechanical
stress. In addition to maintaining cellular homeostasis, autophagy
Table 1
Summary of TM cells.
Cell line Donor age (yr) Glaucoma
medications
Glaucoma
surgery
hTM1 65 None No
hTM2 67 None No
hTM3 79 None No
gTM1 72 Travatan No
gTM2§ 77 Trusopt, Ocupress, Timoptic No
gTM3§ 81 Timoptic, Xalatan Argon laser
§ [17].
Table 2
List of primary antibodies used.
Target protein Company Catalog number Dilution
Atg3 Cell Signaling 3415P 1:1000
Atg4 Santa Cruz Biotechnology SC-131433 1:1000
Atg5 Cell Signaling 8540P 1:1000
Atg7 Cell Signaling 2631P 1:1000
Atg12 Cell Signaling 4180P 1:1000
Beclin Cell Signaling 3495P 1:1000
p62 Sigma-Aldrich P0067 1:1000
LAMP1 Abcam Ab24170 1:1000
CTSD Santa Cruz Biotechnology SC-6494 1:1000
CTSB Abcam ab58802 1:1000
LC3B Cell Signaling 3868S 1:1000
pRPS6KB(T421/S424) Santa Cruz Biotechnology SC-7984 1:1000
pRPS6KB(T389) Cell Signaling 9205 1:1000
RPS6KB Santa Cruz Biotechnology SC-230 1:1000
Actin Santa Cruz Biotechnology sc-69879 1:2000
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development, as well as prevention of cancer, neurodegeneration and
aging [8]. Defects in autophagy have been linked to the progressive de-
terioration occurring during aging [9], and in an increasing number of
diseases, including ocular diseases [10].
The TM is a dynamic tissue continuously exposed to different types
of stresses, such as oxidative stress, mechanical stress, shear stress,
and phagocytic stress [11]. Although short-term exposure to these
stresses is expected to elicit adaptive responses, long-term exposure
may lead to permanent alterations in the tissue physiology and contrib-
ute to the pathologic increase in aqueous humor outﬂow resistance
frequently associated with glaucoma. Very recently, our laboratory has
shown that activation of autophagy in TM cells is an early event
occurring after application of sustained biaxial stretch, as well as in
perfused eyes subjected elevated IOP [12]. In different studies, our
laboratory demonstrated the induction of autophagy in TM cells sub-
jected to chronic oxidative stress [5,6], a condition associated with the
pathogenesis of glaucoma. In these studies, however, concomitant
with the activation of the autophagic pathway, we observed reduced ly-
sosomal acidiﬁcation and impaired proteolytic maturation of lysosomal
enzymes, resulting in decreased autophagic ﬂux.
The importance of the autophagic lysosomal pathway in outﬂowpath-
way physiology is supported by the observation that elevated IOP and
POAG are some of the ocularmanifestations described in patientswith ly-
sosomal storage disorders [13,14]. Also, of extreme relevance is the fact
that ASB10, a novel candidate POAG gene, has been recently reported to
participate in ubiquitin-mediated degradation pathways [15]. Very inter-
estingly, autophagy participates in the cellular degradation of myocilin, a
gene linked to juvenile- and adult-open angle glaucoma [16]. Despite
these data, and the observed role of autophagy in response to stress and
adaptation in TMcells, the only example in the literature showing the sta-
tus of the autophagic lysosomal pathway in glaucomatous TM cells is that
inferred from the SA-β-Gal staining. Here, we systematically compared
the autophagic function of TM cells isolated from glaucomatous and
age-matched donor eyes.
2. Materials and methods
2.1. Cell culture
Primary cultures of human TM cells were prepared and maintained
as previously described [17]. Brieﬂy, the TMwas dissected and digested
with 2 mg/ml of collagenase for 1 h at 37 °C. The digested tissue
was placed in gelatin-coated 35 mm dishes and cultivated in low
glucose Dulbecco's Modiﬁed Eagle Medium (DMEM) with l-glutamine
and 110 mg/l sodium pyruvate, supplemented with 10% fetal
bovine serum (FBS), 100 mM non-essential amino acids, 100 units/ml
penicillin, 100mg/ml streptomycin sulfate and 0.25 mg/ml amphotericin
B; all the reagents were obtained from Invitrogen (Carlsbad, CA). Cells
weremaintained and propagated until passage three at 37 °C in a humid-
iﬁed airwith 5%CO2 incubator. Primary cultures of humanTMcells (hTM)
were isolated from corneoscleral rims from non-glaucomatous donor
eyes after corneal transplantation surgery at Duke University Eye Center.
Primary cultures of glaucomatous TM cells (gTM)were prepared from ca-
daver eyes obtained less than 24 h post-mortem from donors with docu-
mented history of POAG [17]. Ages and glaucoma medications of eye
donors are summarized in Table 1. The protocols involving the use of
human tissuewere consistentwith the tenets of theDeclaration ofHelsin-
ki. Cell lines were subcultivated 1:2 when conﬂuent. Cells at passage four
were used for all the experiments.
2.2. Experimental model of chronic oxidative stress
Chronic oxidative stress was induced by subjecting the cells to
normobaric hyperoxic conditions as described before [5]. Brieﬂy,
human TM cells were grown for two weeks at 40% O2 and 5% CO2 atconﬂuency. Control cultures were grown under physiological oxygen
conditions (5% O2, 5% CO2) in a triple-gas incubator (SANYO, MCO-5M).
2.3. Whole-cell lysate preparation
Cellswerewashed twice in PBS and lysated in RIPA buffer containing
protease inhibitor cocktail (Thermo Scientiﬁc) and phosphatase inhibi-
tor cocktail (Thermo Scientiﬁc). After sonication for 1min on ice, lysates
were clariﬁed by centrifugation. Cytoplasmic and nuclear lysates were
obtained as follows. Cells were washed and incubated on ice for
15 min in Triton X-100 lysis buffer (50 mMTris–HCl pH 7.5, 0.5% Triton
X-100, 137.5mMNaCl, 10% Glycerol, with protease and phosphatase in-
hibitors). Protein concentrationwas determinedwith a protein assay kit
(Micro BCA, Thermo Scientiﬁc).
2.4. Western blot analysis
Protein samples (10 μg)were separated by 10% polyacrylamide SDS-
PAGE gels (15% polyacrylamide for LC3 detection, 7% polyacrylamide for
LAMP1 detection) and transferred to PVDF membranes (Bio-Rad). The
membranes were blocked with 5% nonfat dry milk and incubated over-
night with the speciﬁc primary antibodies (Table 2). The bands were
detected by incubation with a secondary antibody conjugated to horse-
radish peroxidase and chemiluminescence substrate (ECL Plus, GE
Healthcare). Blots were scanned and analyzed by densitometry using
Image J.
2.5. Measurement of endogenous cellular lipofuscin autoﬂuorescence
Endogenous lipofuscin autoﬂuorescence was detected under the
FITC ﬁlter byﬂuorescencemicroscopy and quantiﬁed byﬂow cytometry
(FACSCalibur; BD Biosciences). For this, cells were trypsinized, washed
in PBS, and resuspended in 100 μL PBS. The ﬂuorescence emitted
by 10,000 cells in the emission wavelength of the lipofuscin (yellow–
orange spectrum, FL-2 channel, 563–607 nm wavelength band) when
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software; BD Biosciences).2.6. Quantiﬁcation of lysosomal cellular content
The lysosomal cellular content was evaluated using the
lysosomotropic dye Lysotracker Red (LTR, Invitrogen) following the
manufacturer's instructions. Brieﬂy, cells were incubated for 15 min at
37 °C in fresh culture medium containing LTR (500 nM). Speciﬁc lyso-
somal labeling was conﬁrmed by ﬂuorescence microscopy. Cells were
then washed, trypsinized and resuspended in 100 μL PBS. LTR ﬂuores-
cence was quantiﬁed by ﬂow cytometry. The ﬂuorescence emitted by
10,000 cells in the FL-3 channel (red spectrum) when excited with
the 488 nm laser was recorded and analyzed (CellQuest software;
BD Biosciences).2.7. Flow cytometry determination of SA-β-Gal activity
Quantiﬁcation of SA-β-Gal activitywas performedbyﬂow cytometry
with the ﬂuorogenic substrate C12FDG (Invitrogen). First, alkalinization
of the lysosomal compartment was induced by treating cell monolayers
with 300 μM chloroquine for 1 h at 37 °C under 5% CO2. The cells
(1 × 106) were then trypsinized and incubated for 1 min at 37 °C in
50 μL of pre-warmed PBS containing C12FDG (33 μM). C12FDG uptake
was stopped by adding 500 μL ice-cold PBS. The mean green ﬂuores-
cence of 10,000 cells was recorded (FL-1 channel) 30 min later and
quantiﬁed (CellQuest software; BD Biosciences). Nonstained control
cells were included, to evaluate the baseline ﬂuorescence. The laser in-
tensity settings were adjusted to the lowest level so as not to detect
autoﬂuorescence.2.8. Proteolysis assay
Cells were labeled with 2 μCi/ml [3H]Leucine (MP Biomedicals) for
48 h tomaximize labeling of long-lived proteins. At the end of the label-
ing period, cells were washed ﬁve times with PBS and incubated with
chase medium containing 50 times the molar concentration of leucine
for 2 h to chase-out short-lived proteins. Chase medium was then
replaced, and cells were incubated with fresh chase medium for 16 h.
Culture media containing free [3H]Leucine released upon intracellular
degradation was collected, clariﬁed by centrifugation at 500 g× 5 min
and precipitated overnight at 4 °C in a ﬁnal concentration of 10% trichlo-
roacetic acid. Cellswerewashed and lysed in solubilization buffer (0.1 N
NaOH, 0.1% sodium deoxycholate) at 37 °C for 2 h. Radioactivity was
counted in the acid-soluble fraction and in the solubilized cells. Proteol-
ysis was calculated by dividing the soluble radioactivity count per min-
ute (cpm) by the total cellular radioactivity cpm.Fig. 1. SA-β-Gal, lipofuscin, and lysosomal content in normal and glaucomatous human TM cell
(gTM)donor eye tissueswere taken to passage four and then grown to conﬂuence; SA-β-Gal act
at day ﬁve post-conﬂuence. Experiments were performed in duplicate, n= 6, t-test.2.9. Statistical analyses
All experimental procedures were conducted with the three non-
glaucomatous and glaucomatous primary cultures listed in Table 1.
The percentage of increase of the experimental conditions compared
with the control was calculated and averaged. Data are represented as
the mean ± SD and were analyzed with unpaired or paired Student's
t-test. P b 5% was considered statistically signiﬁcant.
3. Results
3.1. SA-β-Gal, lipofuscin, and lysosomal content in glaucomatous and
control cultured HTM cells
Primary gTM cells displayed a signiﬁcant increase in SA-β-Gal activ-
ity compared to primary hTM cells (Fig. 1A, 95.03 ± 7.89 vs. 32.14 ±
10.92 RFU, p = 0.009). The levels of cellular autoﬂuorescence, which
represents lipofuscin or intralysosomal non degradable material, were
also higher in glaucomatous cultures (Fig. 1B, 26.15 ± 1.548 vs.
20.72 ± 1.522 RFU, p = 0.066). Although not statistically signiﬁcant,
a trend towards diminished lysosomal mass was observed in
glaucomatous cells compared to control cells (Fig. 1C, 74.01 ± 16.84
vs. 95.62 ± 28.58 RFU, p= 0.55).
3.2. Steady state expression levels of autophagy and lysosomal proteins in
glaucomatous and control cultured TM cells
A connection between autophagy and SA-β-Gal activity has been
suggested in several studies [4,18–22], including our previous work [5,
6]. To assess a potential difference in the autophagy lysosomal pathway
between gTM and hTM, we evaluated by Western-blot the steady state
expression levels of a number of autophagy (Atg3, Atg4, Atg5, Atg7,
Atg12, Beclin, LC3B) and lysosomal proteins (LAMP1, CTSD, CTSB), as
well as that of p62, a scaffold protein that targets ubiquitinated proteins
for autophagic degradation. Blots and densitometry quantiﬁcation of
the protein bands are shown in Fig. 2A and B, respectively. Despite the
expected variability among the samples, all gTM primary cultures dem-
onstrated a signiﬁcant decrease in p62 (0.873 ± 0.171 vs. 1.035 ±
0.238 AU, p = 0.05), single chain CTSB (0.359 ± 0.199 vs. 0.783 ±
0.167 AU, p= 0.04), and LC3B-II (0.418 ± 0.358 vs. 0.816 ± 0.468 AU,
p = 0.032) protein levels. A decrease in Atg7 was also observed
(0.686± 0.29 vs. 0.89± 0.37 AU, p=0.08). LAMP1, a lysosomal mem-
brane protein, was found to be downregulated in two of the gTM
cultures, but highly expressed in the third one.
3.3. Mechanistic target of rapamycin (mTOR) pathway
The kinase TOR is a critical regulator of autophagy induction, with
activatedmTOR suppressing, and negative regulation of mTOR promot-
ing autophagy. We investigated the status of mTOR pathway bys: Primary cultures of TM cells isolated from three normal (hTM) and three glaucomatous
ivity (A), lipofuscin content (B), and lysosomalmass (C)were quantiﬁedbyﬂow cytometry
Fig. 2. Expression levels of autophagy and lysosomal proteins in hTM and gTM. (A) Steady state expression levels of autophagy and lysosomal proteins in hTM and gTM cells at passage
four grown to conﬂuence for ﬁve days, evaluated by WB. (B) Normalized relative protein levels calculated from densitometric analysis of the blots. Data are the means ± SD,
n = 3, * p b 0.05, t-test.
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Kinase (RPS6KB/p70S6K). Two different rapamycin-sensitive phos-
phorylation sites were analyzed (the mTOR directly phosphorylated
site Thr389, and the Thr421/Ser424 at the pseudosubstrate region). As
observed in Fig. 3A and quantiﬁed in Fig. 3B, all gTM cultures showed
a signiﬁcant increase in the relative protein levels of pRPS6KB-T389
compared to hTM (1.23 ± 0.6 vs. 0.05 ± 0.3, p b 0.0001). In contrast,
the levels of pRPS6KB-T421/S424 were signiﬁcantly reduced in the
glaucomatous cells (0.06 ± 0.6 vs. 1.43 ± 0.31, p b 0.0001).
3.4. Proteolysis of long-lived and total protein synthesis
Proteolysis of long-lived proteins in conﬂuent cultures of hTM cells
and gTM cells was measured using a radiolabeled amino acid-based
pulse chase assay. As shown in Fig. 4A, gTM cultures showed a small
but signiﬁcant ∼10% decrease in the autophagic degradation of long
lived proteins, compared to control cultures (0.168 ± 0.002 vs
0.185 ± 0.005 cpm, p= 0.034). Moreover, the amount of [3H]-Leu in
the intracellular fraction, which correlates with total protein synthesis,
was signiﬁcantly reduced in gTM cells (Fig. 4B, 17019 ± 2476 vs.
6420.7 ± 1280.5 cpm, p= 0.032).3.5. Autophagy and oxidatively stressed hTM and gTM cells
Our laboratory previously reported the induction of autophagy in por-
cine TM cells exposed to chronic oxidative stress. Concomitant with the
activation of the autophagic pathway, TM cells grown under oxidative
stress conditions showed reduced autophagic ﬂux and lysosomal proteol-
ysis [5,6]. Wewanted to investigate the autophagic response of gTM cells
when subjected to chronic oxidative stress. For this, conﬂuent cultures
of hTM cells and gTM cells were grown for 10 days under hyperoxia
(40% O2); controls were kept under physiological 5% O2 concentrations,
an experimentalmodel previously validatedbyour laboratory for applica-
tion of chronic oxidative stress in post-mitotic TM cells [5]. LC3B-II levels
and proteolysis of long-lived proteins were evaluated. While all hTM cul-
tures demonstrated elevated LC3B-II levels when grown under 40% O2
conditions, a signiﬁcant increase in LC3B-II in response to an oxidative en-
vironment was observed in just one out of the three gTM cultures tested
(Fig. 5A and B). In agreement with our previous study using porcine TM
cells, proteolysis of long-lived proteinswas signiﬁcantly reduced in oxida-
tively stressed cultures when compared to non-stressed ones (Fig. 5C).
Such decrease in proteolysis with oxidative stress was more pronounced
in gTM than in hTM cells.
Fig. 3. mTOR pathway in hTM and gTM cells. (A) Protein levels of phosphorylated and
non-phosphorylated downstream target of MTOR, RPS6KB. (B) Normalized relative pro-
tein levels of pRPS6KB calculated from densitometric analysis of the blots. Data are the
means ± SD, n= 3, *** p b 0.001, t-test.
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In this manuscript we have characterized for the ﬁrst time the au-
tophagic function of glaucomatous TM cells. Our data indicate dysregu-
lation of the autophagic pathway and autophagic response to oxidative
stress in TM cells isolated from the glaucomatous outﬂow pathway.
The study of autophagy in glaucomatous human cadaver tissue is
subjected to important limitations and challenges. First, the supply of
human cadaver eyes for research purposes has been and it is gradually
declining over the last few years [23]; second, access to complete clini-
cal histories can be challenging; third and most importantly, all glauco-
ma patients undergo therapy with glaucoma medications, usually a
combination of different drugs, and/or might have undergone surgery,
either laser or trabeculectomy. So far, there is no information of the ef-
fects of these therapeutic treatments in the autophagic lysosomal path-
way, which might deﬁnitively affect the outcome. To overcome some of
these limitations, we have opted for ﬁrst characterizing the autophagic
lysosomal function in glaucomatous TM cells as a starting point. We ac-
knowledge that glaucomatous cells in vitro likely behave different than
those in vivo conditions, but so do control cultures. The fact that results
are observed across glaucomatous cell strains from 3 donors with glau-
coma and 3 donors that were ostensibly non-glaucomatous, supports
and strengths the signiﬁcance of our results.Fig. 4. Proteolysis of long-lived proteins and total protein synthesis in hTM and gTM cells.
Primary cultures of hTM and gTM cells at passage four were grown to conﬂuence for ﬁve
days. (A) Cellular proteolysis as calculated by dividing the soluble radioactivity (cpm)
found in the culture media by the total cellular radioactivity (cpm). (B) Total protein syn-
thesis calculated by the amount of [3H]-Leu in the intracellular fraction. Experimentswere
performed in duplicate, n= 3, t-test.Very strikingly, we found that glaucomatous TM cells conserve
in vitro the increase in SA-β-Gal activity we previously reported in
situ in the glaucomatous outﬂow pathway [2]. Although the average
age in the glaucoma group (76.67 ± 4.51 y.o.) is slightly, but not
signiﬁcant, higher than in the control group (70.33 ± 7.57 y.o.), we
did not ﬁnd a correlation with aging when looked at data individually,
whichmight account for such a difference. SA-β-Gal activity is encoded
by the lysosomal β-galactosidase [24], but the molecular mechanisms
underlying its expression and its functional relevance in senescence
and other non-senescent conditions (i.e low serum level or high
conﬂuency) are not fully understood. SA-β-Gal has been proposed to
be a surrogate marker for the increase in lysosomal mass occurring dur-
ing aging [25]. However, the lower levels of the lysosomal membrane
protein LAMP1 found in two out of the three glaucomatous TM cultures,
together with the observed trend towards decreased lysosomal mass
in gTM cells, suggest that although both phenomena might occur
simultaneously, they are not strictly dependent.
Impairment of autophagy has been shown to induce SA-β-Gal in pri-
mary human ﬁbroblasts [19]. Very interestingly, all glaucomatous TM
cells display lower steady-state levels of the autophagosome marker
LC3B-II compared to their respective controls. Because of limited cell
availability, we could not perform a proper ﬂux assay to assess whether
such decrease in the steady-state levels of LC3B-II was a result of
impaired autophagic activation or reduced autophagic ﬂux [26,27]. In-
triguingly, our data pointed in both directions. On one hand, along
with the decreased in LC3B-II, glaucomatous TM cells demonstrated in-
creased presence of intralysosomal non-degradable material, reduced
proteolysis of long-lived proteins, and lower lysosomal content,
altogether suggesting a decrease in autophagic ﬂux. On the other
hand, gTM cultures also showed signiﬁcantly lower amounts of p62.
Protein levels of p62 have been used as a readout for autophagic
degradation; however, as recently indicated in [27], there is not always
a clear correlation between LC3B-II and p62.
The best well-known pathway regulating autophagy is mTOR
signaling, which inversely regulates autophagic ﬂux and protein syn-
thesis [18,28,29]. mTOR activity is commonly monitored following the
phosphorylation of its downstream substrate RPS6KB [27]. Very
interestingly, gTM cells showed a dramatic increase in the levels of
RPS6KB phosphorylated at Thr389 (pRPS6KB-T389), a direct mTOR
phosphorylation site, indicating constitutive inhibition of autophagy
in glaucomatous TM cells. Intriguingly, phosphorylation of RPS6KB
at the other rapamycin-sensitive phosphorylation site examined,
Thr421/Ser424, was signiﬁcantly reduced in the glaucomatous cultures.
Phosphorylation of these residues is believed to activate the kinase,
raising the possibility that other signaling pathway participating in
fully activation of RPS6KB are dysregulated in glaucoma. Amajor down-
side outcome of RPS6KB inhibition is diminished protein synthesis [30].
In agreement, gTM cells showed an almost 50% reduction in intracellu-
lar incorporation of 3H-Leu into nascent proteins.
The glaucomatous TM tissue is characterized by the increased ex-
pression of oxidative markers (oxidative DNA damage and peroxidized
lipids) as well as diminished overall antioxidant potential [31–33].
Although the molecular mechanisms are not clear yet, oxidative stress
is believed to play a major role in the pathogenesis of POAG [34,35],
likely as a result of the particular higher sensitivity of the TM to oxida-
tive radicals compared with other tissues in the anterior chamber of
the eye [36]. In contrast to control cells, gTM cells failed to activate au-
tophagy in response to chronic oxidative stress. Moreover, exposure to
a hyperoxic environment further decreased lysosomal proteolysis in
the glaucomatous cultures, supporting a key role of autophagy in the
TM cellular response to oxidative stress.
Interestingly, a recent work by Pulliero et al. has reported a parallel
increase in oxidative damage and increase LC3-II/LC3-I protein levels
in TM tissue with aging [37]. These results do not contradict, rather
complement our ﬁndings here. In cultured conditions, oxidative stress
is known to induce autophagy in TM cells, as an early protective
Fig. 5.Autophagy in oxidatively stressed hTMand gTM cells. Conﬂuent cultures of hTMand gTMcells at passage fourwere grown for 10days either at physiological 5%O2 concentrations or
under hyperoxia (40% O2). (A) Protein expression levels of LC3B-I and LC3B-II. (B) Normalized relative protein levels calculated from densitometric analysis of the blots. (C) Cellular
proteolysis as calculated by dividing the soluble radioactivity cpm found in the culture media by the total cellular radioactivity cpm. Data are the means ± SD, n= 3, ⁎,# p b 0.05,
⁎⁎ p b 0.01, t-test.
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agic function [6]. Biphasic changes in autophagy are not unusual and are
considered to contribute to disease progression in other tissues [38].
Similar to our ﬁndings here, the oxidatively stressed cultures also
demonstrated increased SA-β-Gal, which seemed to be, at least, partly
mediated by activation of autophagy and associated with decreased au-
tophagic ﬂux [6]. It is, therefore, possible that mechanisms related to
those observed in oxidatively stressed TMcells lead to defective autoph-
agic degradation in glaucoma disease.
In conclusion, the data presented here strongly support mTOR-
dependent dysregulation of autophagy in glaucomatous TM cells. As
discussed in [39], such dysregulated autophagic capacity can have a det-
rimental impact in outﬂowpathway tissue functionality, i.e. its ability to
cope and adapt to mechanical forces, including those triggered by high
pressure [12], and represent an important factor contributing to the
progressive failure of cellular TM function with age and contribute to
the pathogenesis of ocular hypertension and POAG.
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